Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1997-10-20
2000-08-01
Chin, Christopher L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241921, 4241931, 42419511, 424 851, 424 854, 424 855, 435 695, 435 697, 530350, 530351, A61K 39102
Patent
active
060963204
ABSTRACT:
New chimeric proteins, DNA encoding the same, and the use of these proteins in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The chimeric proteins include at least one epitope of an RTX cytotoxin fused to an active fragment of a cytokine. The chimeric proteins can be used in a vaccine composition. Also disclosed are methods of vaccination as well as methods of making the proteins employed in the vaccines.
REFERENCES:
patent: 3328252 (1967-06-01), Mora
patent: 4167560 (1979-09-01), Wohler, Jr.
patent: 4171354 (1979-10-01), Smith
patent: 4328210 (1982-05-01), Kucera
patent: 4346074 (1982-08-01), Gilmour et al.
patent: 4366246 (1982-12-01), Riggs
patent: 4675382 (1987-06-01), Murphy
patent: 4704362 (1987-11-01), Itakura et al.
patent: 4818769 (1989-04-01), Nunberg et al.
patent: 4933299 (1990-06-01), Greenfield
patent: 4935233 (1990-06-01), Bell et al.
patent: 4957739 (1990-09-01), Berget et al.
patent: 5028423 (1991-07-01), Prickett
patent: 5071761 (1991-12-01), Meyer et al.
patent: 5095096 (1992-03-01), Miki et al.
patent: 5108910 (1992-04-01), Curtis et al.
patent: 5114711 (1992-05-01), Bell et al.
patent: 5476657 (1995-12-01), Potter
Cho et al., Can. J. Vet. Res. (1986) 50:27-31.
Cho et al., Can. J. Comp. Med. (1984) 48:151-155.
Conlon et al., Infect. Immun. (1991) 59(2):587-591.
Czarniecki et al., J. Interferon Res. (1986) 6:29-37.
Donanche et al., J. Gen. Microbiol. (1984) 130:1209-1216.
Gentry et al., Vet. Immunology and Immunopathology (1985) 9:239-250.
Highlander et al., DNA (1989) 8:15-28.
Himmel et al., Am. J. Vet. Res. (1982) 43:764-767.
Lally et al., Biochem Biophys. Res. Comm. (1989) 159(1):256-262.
Lawman et al., Comprehensive Biotech, First Supplement, Animal Biotechnology (1989) Pergamon Press, London, pp. 63-106.
Lessley et al., Veterinary Immunology and Immunopathology (1985) 10:279-296.
Lo et al., Infect. Immun. (1985) 50:667-671.
Lorberboum-Galski et al., Proc. Natl. Acad. Sci. USA (1988) 85:1922-1926.
Martin et al., Can. J. Comp. Med. (1980) 44:1-10.
Shewen et al., Am. J. Vet. Res. (1983) 44:715-719.
Shewen et al., Can. J. Vet. Res. (1988) 52:30-36.
Strathdee et al., J. Bacteriol. (1989) 171(2):916-928.
Strathdee et al., Infect. Immun. (1987) 55(12):3233-3236.
R. A. Welch, Pore-forming cytolysins of Gram-negative bacteria, Molecular Microbiology, (1991), 5(3):521-528.
Williams et al., Protein Eng. (1987) 1(6):493-498.
Yates Can. J. Comp. Med. (1982) 46:225-263.
Campos Manuel
Hughes Huw P. A.
Potter Andrew
Chin Christopher L.
Ciba-Geigy Canada Ltd.
Graser Jennifer
University of Saskatchewan
LandOfFree
Vaccines with chimeric protein comprising gamma-interferon and l does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines with chimeric protein comprising gamma-interferon and l, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines with chimeric protein comprising gamma-interferon and l will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-661068